Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling. [electronic resource]
Producer: 20170905Description: 23-30 p. digitalISSN:- 1872-6240
- Animals
- Antioxidants -- pharmacology
- Apoptosis -- drug effects
- Corpus Striatum -- metabolism
- Dopaminergic Neurons -- metabolism
- Ellagic Acid -- metabolism
- Estrogen Receptor beta -- antagonists & inhibitors
- Heme Oxygenase (Decyclizing)
- Malondialdehyde
- Models, Animal
- Monoamine Oxidase
- NF-E2-Related Factor 2
- Neostriatum -- metabolism
- Neuroprotective Agents -- therapeutic use
- Oxidative Stress -- drug effects
- Oxidopamine -- pharmacology
- Parkinson Disease -- drug therapy
- Pars Compacta -- metabolism
- Rats
- Reactive Oxygen Species
- Signal Transduction -- drug effects
- Substantia Nigra -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.